Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19 - Authors' reply.
作者信息
Bovijn Jonas, Lindgren Cecilia M, Holmes Michael V
机构信息
Big Data Institute at the Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, OX3 7FZ, UK.
Medical Research Council Population Health Research Unit (MRC PHRU), Nuffield Department of Population Health, University of Oxford, Oxford, OX3 7LF, UK.
出版信息
Lancet Rheumatol. 2021 Feb;3(2):e97-e98. doi: 10.1016/S2665-9913(20)30415-X. Epub 2020 Dec 15.
Abstract
摘要
相似文献
1
Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19 - Authors' reply.新冠病毒疾病中白细胞介素-6受体基因变体与白细胞介素-6受体信号传导的治疗性抑制——作者回复
Lancet Rheumatol. 2021 Feb;3(2):e97-e98. doi: 10.1016/S2665-9913(20)30415-X. Epub 2020 Dec 15.
2
Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19.新冠病毒疾病中白细胞介素-6受体的基因变异及白细胞介素-6受体信号传导的治疗性抑制
Lancet Rheumatol. 2021 Feb;3(2):e96-e97. doi: 10.1016/S2665-9913(20)30416-1. Epub 2020 Dec 15.
3
Identification of IL-6 Signalling Components as Predictors of Severity and Outcome in COVID-19.鉴定白细胞介素 6 信号通路组分作为 COVID-19 严重程度和预后的预测因子。
Front Immunol. 2022 May 13;13:891456. doi: 10.3389/fimmu.2022.891456. eCollection 2022.
4
Hitting a complex target: an update on interleukin-6 trans-signalling.直击复杂靶点：白细胞介素-6 转导信号的最新研究进展。
Expert Opin Ther Targets. 2012 Feb;16(2):225-36. doi: 10.1517/14728222.2012.660307.
5
Synthetic trimeric interleukin-6 receptor complexes with a STAT3 phosphorylation dominated activation profile.具有 STAT3 磷酸化主导激活特征的合成三聚体白细胞介素-6 受体复合物。
Cytokine. 2024 Dec;184:156766. doi: 10.1016/j.cyto.2024.156766. Epub 2024 Sep 29.
6
EZH2 promotes angiogenesis in peritoneal dialysis by epigenetically activating SP4 expression in the IL-6/sIL-6R signalling pathway.EZH2 通过在 IL-6/sIL-6R 信号通路中表观遗传激活 SP4 的表达促进腹膜透析中的血管生成。
Int J Med Sci. 2023 Jan 1;20(1):114-124. doi: 10.7150/ijms.78428. eCollection 2023.
7
Leveraging genetic data to investigate the effects of interleukin-6 receptor signalling on levels of 40 circulating cytokines.利用遗传数据研究白细胞介素-6受体信号传导对40种循环细胞因子水平的影响。
Br J Clin Pharmacol. 2022 Mar;88(3):1373-1378. doi: 10.1111/bcp.15079. Epub 2021 Oct 7.
8
Increased IL-6 and Potential IL-6 trans-signalling in the airways after an allergen challenge.过敏原刺激后气道中白细胞介素 6（IL-6）的增加和潜在的 IL-6 转导信号。
Clin Exp Allergy. 2021 Apr;51(4):564-573. doi: 10.1111/cea.13832. Epub 2021 Feb 2.
9
Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor.在幼年特发性关节炎中，白细胞介素-6信号传导受到蛋白水解切割的可溶性白细胞介素-6受体的限制。
Rheumatology (Oxford). 2006 Dec;45(12):1485-9. doi: 10.1093/rheumatology/kel154. Epub 2006 May 11.
10
IL-6 signalling biomarkers in hospitalised patients with moderate to severe SARS-CoV-2 infection in a single centre study in Sweden.在瑞典的一项单中心研究中，住院的中度至重度严重急性呼吸综合征冠状病毒 2 感染患者的 IL-6 信号生物标志物。
Cytokine. 2022 Nov;159:156020. doi: 10.1016/j.cyto.2022.156020. Epub 2022 Aug 29.
引用本文的文献
1
Identification of host genomic biomarkers from multiple transcriptomics datasets for diagnosis and therapies of SARS-CoV-2 infections.从多个转录组学数据集鉴定宿主基因组生物标志物，用于 SARS-CoV-2 感染的诊断和治疗。
PLoS One. 2023 Mar 13;18(3):e0281981. doi: 10.1371/journal.pone.0281981. eCollection 2023.
2
Identifying factors contributing to increased susceptibility to COVID-19 risk: a systematic review of Mendelian randomization studies.确定导致 COVID-19 易感性增加的因素：孟德尔随机化研究的系统评价。
Int J Epidemiol. 2022 Aug 10;51(4):1088-1105. doi: 10.1093/ije/dyac076.
3
Associations between body composition, fat distribution and metabolic consequences of excess adiposity with severe COVID-19 outcomes: observational study and Mendelian randomisation analysis.与严重 COVID-19 结局相关的肥胖过多的身体成分、脂肪分布和代谢后果之间的关联：观察性研究和孟德尔随机分析。
Int J Obes (Lond). 2022 May;46(5):943-950. doi: 10.1038/s41366-021-01054-3. Epub 2022 Jan 14.
4
Making sense of IL-6 signalling cues in pathophysiology.解析病理生理学中的 IL-6 信号线索。
FEBS Lett. 2022 Mar;596(5):567-588. doi: 10.1002/1873-3468.14201. Epub 2021 Oct 15.
5
A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance.一项蛋白质组学全基因组遗传研究鉴定出了几个与临床相关的新冠病毒利用的宿主靶标。
Elife. 2021 Aug 17;10:e69719. doi: 10.7554/eLife.69719.
本文引用的文献
1
Time to Reassess Tocilizumab's Role in COVID-19 Pneumonia.重新评估托珠单抗在新冠肺炎肺炎中作用的时机
JAMA Intern Med. 2021 Jan 1;181(1):12-15. doi: 10.1001/jamainternmed.2020.6557.
2
Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19.模拟白细胞介素-6受体信号通路治疗性抑制的基因变异与新冠病毒疾病风险
Lancet Rheumatol. 2020 Nov;2(11):e658-e659. doi: 10.1016/S2665-9913(20)30345-3. Epub 2020 Sep 25.
3
COVACTA trial raises questions about tocilizumab's benefit in COVID-19.COVACTA试验引发了关于托珠单抗在新冠病毒肺炎中疗效的质疑。
Lancet Rheumatol. 2020 Oct;2(10):e592. doi: 10.1016/S2665-9913(20)30313-1. Epub 2020 Sep 9.
4
Interleukin-6 Signaling Effects on Ischemic Stroke and Other Cardiovascular Outcomes: A Mendelian Randomization Study.白细胞介素-6信号传导对缺血性中风及其他心血管结局的影响：一项孟德尔随机化研究
Circ Genom Precis Med. 2020 Jun;13(3):e002872. doi: 10.1161/CIRCGEN.119.002872. Epub 2020 May 12.
5
Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases.功能性 IL6R 358Ala 等位基因损害经典的 IL-6 受体信号转导，并影响多种炎症性疾病的风险。
PLoS Genet. 2013 Apr;9(4):e1003444. doi: 10.1371/journal.pgen.1003444. Epub 2013 Apr 4.
Zotero 插件